MangoRx $99 TRT sales jump 336%, CAC down 54%
Mangoceuticals (NASDAQ: MGRX) reported early traction for a newly launched all-inclusive injectable Testosterone…
Novo Nordisk’s diabetes and weight loss drug sales growth decelerates
Novo Nordisk saw sales growth for its diabetes and obesity care segment slow in the first half of…